Nefiracetam

Nefiracetam

Product Name Nefiracetam
Synonyms DM-9384; DMMPA; DZL-221; Translon; N-(2,6-Dimethylphenyl)-2-oxo-1-pyrrolidineacetamide; 2-(2-Oxopyrrolidin-1-yl)-N-(2,6-dimethylphenyl)acetamide
CAS Number 77191-36-7
Molecular Formula C₁₄H₁₈N₂O₂
Molecular Weight 246.30 g/mol
Appearance White to off-white crystalline powder
Assay (HPLC) ≥ 99.0%
Melting Point 125–129°C
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 10 ppm
Storage Cool, dry, sealed, protected from light

도움이 필요하신가요? 저희 팀에 문의해 주세요

What is Nefiracetam?

Nefiracetam (developmental code DM-9384) is a lipid-soluble nootropic compound belonging to the racetam family.

It is structurally distinct from other racetams due to the presence of a 2,6-dimethylphenyl group attached to the acetamide moiety.

This structural modification confers unique pharmacological properties, including GABAergic modulation (distinguishing it from most other racetams) and neuroprotective effects.

differentiator: Unlike most racetams that act primarily through glutamatergic (AMPA) modulation, Nefiracetam has demonstrated significant GABAergic activity, particularly at GABA-A receptors. This unique dual mechanism (GABAergic + glutamatergic) makes Nefiracetam particularly interesting for research into anxiety, neuroprotection, and cognitive disorders with an anxiety component.

Keywords:Nefiracetam CAS 77191-36-7, DM-9384, DMMPA, Translon, GABA-A modulator, dual-mechanism nootropic, neuroprotection research, racetam family, calcium channel inhibitor, LyvBio Nefiracetam

Racetam Family Comparison:

Compound Solubility Primary Mechanism Unique Property
Piracetam Water AMPA (weak) Parent compound
옥시라세탐 Water AMPA Learning acquisition
Aniracetam Lipid AMPA + nAChR Anxiolytic
Nefiracetam Lipid AMPA + GABA-A GABAergic modulation
프라미라세탐 Lipid AMPA Potent memory enhancement

Important regulatory note: Nefiracetam is not FDA-approved for medical use in the United States. It has been investigated in clinical trials (including for Alzheimer’s disease and stroke recovery) but was not approved. It is available as a research chemical for laboratory use only. LyvBio supplies Nefiracetam strictly for research and development purposes.

 Nefiracetam is a hydrophobic derivative of piracetam, which is generally considered to be a substance responsible for the discovery of calcium channels in the body and the indirect transfer of excitatory signaling substances as a partial agonist of calcium ion channels.  Glycine binding site of NDMA receptor.

Through its effect on the cerebral cortex, nefiracetam can enhance cognitive abilities and prevent learning and memory impairment.

It does not possess muscarinic receptor agonist or antagonist properties, nor does it inhibit acetylcholinease activity.

Therefore, its anti-amnestic and memory-enhancing effects are achieved by improving the release of acetylcholine in the cerebral cortex.

Related Research Products from LyvBio

제품 CAS No. Category Research Application
Piracetam 7491-74-9 Racetam Memory research, comparative studies
Aniracetam 72432-10-1 Racetam AMPA + anxiolytic research
옥시라세탐 62613-82-5 Racetam Learning acquisition research
프라미라세탐 68497-62-1 Racetam Potent memory enhancement
Phenylpiracetam 77472-70-9 Racetam Stimulant + cognition research
Noopept (GVS-111) 157115-85-0 Dipeptide Neuroprotection + cognition

Supplier: LyvBio Co., Ltd.

LyvBio 주식회사. is a GMP-certified supplier of high-purity Nefiracetam for research and development applications.

Supply capabilities:

  • Assay (HPLC): ≥99.0%

  • Form: Crystalline powder

  • Monthly capacity: 10+ kg

  • Bulk quantities: 5g – 10kg

  • Lead time: 3–5 days (samples), 10–15 days (bulk)

  • Documentation: COA, MSDS, TDS, HPLC chromatogram, stability data

Quality assurance:

  • HPLC purity with UV detection

  • Residual solvents tested (meets USP <467>)

  • Heavy metals tested (ICP-MS)

  • Structural confirmation (NMR upon request)

📧 Email: info@lyvbio.com
🌐 Website: https://www.lyvbio.com

연락 유지

견적 요청

주소

280 메인 스트리트, 시안, 산시, 중국

×